Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis
Hongguang Zhang(Soochow University), Hui Zheng(Hunan University), Hang Ruan(Institute of Rock and Soil Mechanics), Yibo Zuo(Institute of Infection and Immunity), Xiangjie Chen(University of Maryland, College Park), Xingshun Xu(Soochow University), Shifeng Li(Soochow University), Yang Yong(Soochow University), Qiuyu Wu(Soochow University), Tengfei Ren(University of Electronic Science and Technology of China), Xuan Liu(Soochow University), Bin Wang(Soochow University), Jun Wang(Harbin Medical University), Junjie Wang(Soochow University), Tingting Guo(Zhejiang Lab), Chunsheng Dong(Soochow University), Yukang Yuan(University of Electronic Science and Technology of China), Ying Miao(Soochow University), Miao Sun(Soochow University)
Cited by 51
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
|Proceedings of the National Academy of Sciences|2013|290
Osteosarcoma and Metastasis
|Frontiers in Oncology|2021|207
Highly‐expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells <i>via</i> PI3K/Akt/GSK3β/β‐catenin and mTOR/HIF1α/VEGF signaling
|International Journal of Cancer|2019|167